Format

Send to

Choose Destination
Immunology. 2016 Dec;149(4):386-399. doi: 10.1111/imm.12656. Epub 2016 Sep 7.

From ZikV genome to vaccine: in silico approach for the epitope-based peptide vaccine against Zika virus envelope glycoprotein.

Author information

1
Centre for Interdisciplinary Research in Basic Science, Jamia Millia Islamia, New Delhi, India.
2
Department of Biotechnology, College of Engineering & Technology, IFTM, Moradabad, India.
3
Centre for Interdisciplinary Research in Basic Science, Jamia Millia Islamia, New Delhi, India. rishrat@jmi.ac.in.

Abstract

Zika virus (ZikV) has emerged as a potential threat to human health worldwide. A member of the Flaviviridae, ZikV is transmitted to humans by mosquitoes. It is related to other pathogenic vector-borne flaviviruses including dengue, West Nile and Japanese encephalitis viruses, but produces a comparatively mild disease in humans. As a result of its epidemic outbreak and the lack of potential medication, there is a need for improved vaccine/drugs. Computational techniques will provide further information about this virus. Comparative analysis of ZikV genomes should lead to the identification of the core characteristics that define a virus family, as well as its unique properties, while phylogenetic analysis will show the evolutionary relationships and provide clues about the protein's ancestry. Envelope glycoprotein of ZikV was obtained from a protein database and the most immunogenic epitope for T cells and B cells involved in cell-mediated immunity, whereas B cells are primarily responsible for humoral immunity. We mainly focused on MHC class I potential peptides. YRIMLSVHG, VLIFLSTAV and MMLELDPPF, GLDFSDLYY are the most potent peptides predicted as epitopes for CD4+ and CD8+ T cells, respectively, whereas MMLELDPPF and GLDFSDLYY had the highest pMHC-I immunogenicity score and these are further tested for interaction against the HLA molecules, using in silico docking techniques to verify the binding cleft epitope. However, this is an introductory approach to design an epitope-based peptide vaccine against ZikV; we hope that this model will be helpful in designing and predicting novel vaccine candidates.

KEYWORDS:

Immune Epitope Database; MHC class; Zika virus; artificial neural network; epitopes; immunogenomics

PMID:
27485738
PMCID:
PMC5095496
DOI:
10.1111/imm.12656
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center